Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Quest Diagnostics Inc (DGX)

Quest Diagnostics Inc (DGX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 16,763,544
  • Shares Outstanding, K 134,766
  • Annual Sales, $ 7,726 M
  • Annual Income, $ 858,000 K
  • 60-Month Beta 1.07
  • Price/Sales 2.02
  • Price/Cash Flow 13.74
  • Price/Book 2.60
Trade DGX with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate 4.09
  • Number of Estimates 8
  • High Estimate 4.63
  • Low Estimate 3.31
  • Prior Year 1.67
  • Growth Rate Est. (year over year) +144.91%

Price Performance

See More
Period Period Low Period High Performance
1-Month
117.07 +7.62%
on 12/29/20
127.69 -1.33%
on 01/13/21
+5.63 (+4.68%)
since 12/18/20
3-Month
117.07 +7.62%
on 12/29/20
130.84 -3.71%
on 10/23/20
+5.16 (+4.27%)
since 10/19/20
52-Week
73.02 +72.54%
on 04/03/20
131.81 -4.42%
on 07/23/20
+18.93 (+17.68%)
since 01/17/20

Most Recent Stories

More News
Federal, Private Tie-Ups Boost COVID-19 Testing Volume

The Department of Health and Human Services (HHS) promises over $22 billion of funding.

BDX : 260.77 (-0.37%)
DGX : 125.99 (+1.29%)
HOLX : 75.99 (-0.14%)
ABT : 112.57 (+1.14%)
QDEL : 201.24 (-1.59%)
Global COVID-19 Diagnostics Market Size Worth USD 11.40 Billion at 7.9% CAGR; Pharmaceutical Giants Such as Abbott and Roche to Pump More Funds for R&D Activities: Fortune Business Insights(TM)

The global COVID-19 diagnostics market size is projected to reach USD 11.40 billion by 2027, exhibiting a CAGR of 7.9% during the forecast period. Uncontrolled spread of the coronavirus worldwide will...

DGX : 125.99 (+1.29%)
SIEGY : 73.5800 (+1.66%)
Rev. Sharpton, Rev. Butts, U.S. Senator-Elect Rev. Warnock and over 100 Leading Black Clergy Convene on MLK Day to Confront COVID-19 in the Black Community

, /PRNewswire/ -- Today, on Day, a group of the nation's most renowned Black clergy led by Rev. and Rev. , III hosted the Choose Healthy Life Black Clergy Conclave. The event brought together over...

DGX : 125.99 (+1.29%)
Quest Diagnostics (DGX) COVID-19 Test Sales Solid, Volume Dull

Quest Diagnostics (DGX) notes strong signs of the healthcare system returning to pre-pandemic levels with base testing volume gradually improving.

DGX : 125.99 (+1.29%)
HOLX : 75.99 (-0.14%)
PDCO : 31.76 (-2.37%)
IDXX : 484.93 (-0.93%)
Black and Hispanic/Latinx Americans Less Confident in Ability to Access COVID-19 Vaccines, Treatments and Healthcare than White Americans, Finds Quest Diagnostics Health Trends™ Analysis

, /PRNewswire/ -- A new Quest Diagnostics Health Trends™ study finds that Black and Hispanic/Latinx Americans are nearly two times as likely as White Americans to say their access to COVID-19 vaccines,...

DGX : 125.99 (+1.29%)
Quest Diagnostics Granted CDC Contract to Sequence COVID-19 Gene Variants to Aid Public Health Response to COVID-19

, /PRNewswire/ -- (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has entered into an agreement with the  (CDC) to provide genomic sequencing to...

DGX : 125.99 (+1.29%)
The Zacks Analyst Blog Highlights: Abbott Lab, QIAGEN, Quidel, Hologic and Quest Diagnostics

The Zacks Analyst Blog Highlights: Abbott Lab, QIAGEN, Quidel, Hologic and Quest Diagnostics

DGX : 125.99 (+1.29%)
HOLX : 75.99 (-0.14%)
QGEN : 54.16 (+1.80%)
ABT : 112.57 (+1.14%)
QDEL : 201.24 (-1.59%)
Quest Diagnostics To Release Fourth Quarter And Full Year 2020 Financial Results On February 4

, /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report fourth quarter and full year 2020 results on...

DGX : 125.99 (+1.29%)
Testing Space in Focus Again Thanks to New Wave of Coronavirus

The resurgence in coronavirus infections is drawing attention back to the diagnostic testing space.

BDX : 260.77 (-0.37%)
DGX : 125.99 (+1.29%)
HOLX : 75.99 (-0.14%)
QGEN : 54.16 (+1.80%)
ABT : 112.57 (+1.14%)
LH : 225.74 (+0.91%)
QDEL : 201.24 (-1.59%)
Quest Diagnostics (DGX) Gains As Market Dips: What You Should Know

In the latest trading session, Quest Diagnostics (DGX) closed at $123.63, marking a +0.54% move from the previous day.

DGX : 125.99 (+1.29%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Quest Diagnostics Inc., is the leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its national network of laboratories and patient service centers,...

See More

Key Turning Points

3rd Resistance Point 131.82
2nd Resistance Point 129.49
1st Resistance Point 127.74
Last Price 125.99
1st Support Level 123.66
2nd Support Level 121.33
3rd Support Level 119.58

See More

52-Week High 131.81
Last Price 125.99
Fibonacci 61.8% 109.35
Fibonacci 50% 102.41
Fibonacci 38.2% 95.48
52-Week Low 73.02

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar